The Affordability of Lecanemab, an Amyloid-Targeting Therapy for Alzheimer's Disease: an Eadc-Ec Viewpoint
AuthID
P-00Y-P67
P-00Y-P67
© 2024 CRACS & Inesc TEC - All Rights Reserved Privacy Policy | Terms of Service